GlassScriptPhysician profile
Nadine Persheff
NPI 1609829761
$670.31
in general payments reported to CMS, 2019-2025
13 companies · $56.06 in 2025
The $56.06 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $73.70 · 2021: $156 · 2022: $58.51 · 2023: $70.73 · 2024: $82.93 · 2025: $56.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $127.92 | 2019-2021 | |
| Corium, LLC | $108.10 | 2022-2024 | Azstarys |
| Sobi, INC | $77.34 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $74.57 | 2024-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Cranial Technologies, INC | $66.94 | 2021-2025 | Doc Band |
| Kaleo, INC. | $64.83 | 2019-2024 | Auvi-Q |
| Supernus Pharmaceuticals, INC. | $46.85 | 2021 | |
| Pfizer INC. | $24.09 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.82 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.09 | 2019 | |
| Sanofi Pasteur INC. | $16.71 | 2021 | |
| Ironshore Pharmaceuticals INC. | $15.83 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadine Persheff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.